News Medical

GHIT Fund expands investments in leishmaniasis, diagnostic tests

GHIT Fund will invest in the development of a new point-of-care test for the diagnosis of schistosomiasis. Concurrently, GHIT will further invest in the continued development and registration of a ...
Business Insider

GHIT Fund Invests in Late-stage Trial for Child-friendly "Snail Fever" Medicines--One of the Most Debilitating and Widespread Parasitic Diseases in Africa

TOKYO, March 29, 2017 /PRNewswire-USNewswire/ -- The Global Health Innovative Technology Fund (GHIT Fund), a unique Japanese public-private partnership formed to battle infectious diseases around the ...
News Medical

GHIT Fund invests in phase 3 clinical trial for pediatric formulation of ‘snail fever’ drug

GHIT Fund’s investment of US$4.7 million, with co-funding from its partners, will support a Phase 3 clinical trial in Africa to evaluate a pediatric formulation of praziquantel (PZQ) in children aged ...
Business Insider

GHIT Fund Names Hiroki Nakatani as Board Chair

TOKYO, June 7, 2018 /PRNewswire-USNewswire/ -- The Global Health Innovative Technology Fund (GHIT) today announced its appointment of Hiroki Nakatani, MD, PhD, MHPEd, former World Health Organization ...